NANOTHERM

EUIPO EUIPO 2014 Trademark registered

The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark NANOTHERM was filed as Word mark on 11/03/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/25/2015. The current status of the mark is "Trademark registered".

Extend brand

Trademark Details Last update: May 6, 2024

Trademark form Word mark
File reference 013425202
Application date November 3, 2014
Publication date March 18, 2015
Entry date June 25, 2015
Expiration date November 3, 2024

Trademark owner

Max-Planck-Str. 3
12489 Berlin
DE

Trademark representatives

Lehel Carré Thierschplatz 6 80538 München DE

goods and services

1 Nanoparticles, chemical particles and particles in the nanometre range; Chemicals and biopolymers containing nanoparticles; Nanodots, nanoprobes, magnetic powders, granules, granulates and solid metals, nanometals, magnetite and maghemite, magnetic nanoparticles, in particular superparamagnetic nanoparticles and superparamagnetic iron oxide nanoparticles; Biocompatible polymer nanoparticles, liposomes, coated nanoparticles and nanoparticles containing active substances, all of the aforesaid for use in industry and research, in particular for use in therapy methods, heat therapy methods, heat ablation methods and/or hyperthermia methods
5 Pharmaceutical, veterinary and medical preparations; Pharmaceutical and medical compositions for treatment and/or prophylaxis of malignant or benign tumours and/or cardiovascular diseases; Diagnostic preparations, diagnostic agents, pharmaceutical and medical compositions containing magnetic particles, in particular magnetic nanoparticles, superparamagnetic nanoparticles and nanoparticles comprising iron oxide; Magnetic powders, granules, granulates and solid metals; Metallic or magnetic particles, in particular nanoparticles for medical applications, in particular for use as anti-carcinogenic agents and/or anti-neoplastic agents, for use as medical preparations for treating malignant or benign tumours, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases, and for use in heat therapy methods, heat ablation methods and/or hyperthermia methods; contrast substances for medical purposes; Medical preparations for treatment and/or prophylaxis of malignant or benign tumours, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases; Medical preparations for use in heat therapy methods, heat ablation methods and/or hyperthermia methods, in particular medical preparations containing magnetic particles, in particular magnetic nanoparticles, superparamagnetic nanoparticles and nanoparticles containing iron oxide, magnetic powders, granules, granulates and solid metals
42 Medical and scientific research and services in the field of cancer and/or cardiovascular treatment and diagnosis; Development and design of medical preparations containing magnetic particles, in particular magnetic nanoparticles, superparamagnetic nanoparticles and nanoparticles containing iron oxide, all of the aforesaid for treating and/or diagnosing cancers and/or cardiovascular diseases; Providing of medical tests, diagnostic services and information in the field of cancer and/or cardiovascular research and treatment
44 Medical services, in particular in the field of cancer therapy and/or cardiovascular therapy, cancer treatment and/or cardiovascular treatment and cancer and/or cardiovascular diagnosis by administering diagnostic agents and/or pharmaceutical and medical preparations; Containing magnetic particles or by means of conducting therapeutic or diagnostic methods based on medical preparations, in particular based on magnetic nanoparticles; Superparamagnetic nanoparticles and nanoparticles containing iron oxide; Medical services, In particular treatment and/or prophylaxis of malignant or benign tumours, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases, Medical services, In particular conducting of heat therapy methods, heat ablation methods and/or hyperthermia methods

Trademark history

Date Document number Area Entry
April 7, 2024 Extension, Notification of expiry of trade mark
February 21, 2022 Change Representative, Published
January 16, 2019 Change Representative, Published
January 16, 2019 Change Representative, Published
January 26, 2018 RAW: Rights in rem - Creation of rights in rem, Published

ID: 11013425202